Australia markets closed

bluebird bio, Inc. (BLE.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
15.900.00 (0.00%)
At close: 04:13PM CET
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
53,651
250,734
44,674
54,579
Cost of revenue
48,856
5,396
2,978
885
Gross profit
4,795
245,338
41,696
53,694
Operating expenses
Research development
566,708
587,956
582,413
448,589
Selling general and administrative
306,682
286,896
271,362
174,129
Total operating expenses
873,390
874,852
853,775
622,718
Operating income or loss
-868,595
-629,514
-812,079
-569,024
Total other income/expenses net
2,068
-34
-12,835
-1,038
Income before tax
-863,778
-618,009
-790,153
-555,438
Income tax expense
422
686
-545
187
Income from continuing operations
-864,200
-618,695
-789,608
-555,625
Net income
-864,200
-618,695
-789,608
-555,625
Net income available to common shareholders
-864,200
-618,695
-789,608
-555,625
Basic EPS
-
-9.95
-14.31
-10.68
Diluted EPS
-
-9.95
-14.31
-10.68
Basic average shares
-
62,178
55,191
52,032
Diluted average shares
-
62,178
55,191
52,032
EBITDA
-
-610,158
-794,645
-551,866